EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of Baseline Best-Corrected Visual Acuity on Outcomes with Aflibercept 8 mg in Patients with Diabetic Macular Edema

Michael Javaheri, Priya S Vakharia, Talia R Kaden, Sean Adrean, Philip J Ferrone, Xiaomeng Niu, Jenfue Maa, Sharad Rastogi, Disha Patel, Hadi Moini, Kimberly Reed, Alyson J Berliner und 1 weitere

Ophthalmology Retina · 2026-08 · 10 (8) · 887-890

DOI: 10.1016/j.oret.2026.03.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology Retina, 2026-08. Verfasst von Michael Javaheri und 12 weiteren Autor:innen. Beteiligte Einrichtung: Retina Specialists of Beverly Hills, Beverly Hills, California. Electronic address: mikejavaheri@gmail.com. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Regeneron Pharmaceuticals Inc, Bayer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AfliberceptBest-corrected visual acuityCentral retinal thicknessDiabetic macular edema

Autor:innen und Institutionen

  • Retina Specialists of Beverly Hills, Beverly Hills, California. Electronic address: mikejavaheri@gmail.com.
  • Retina Vitreous Associates of Florida, Palm Harbor, Florida.
  • Department of Ophthalmology, Manhattan Eye, Ear, and Throat Hospital, Northwell Health System, New York, New York; Department of Ophthalmology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstea…
  • Retina Consultants of Orange County, Fullerton, California.
  • VitreoRetinal Consultants of New York, Great Neck, New York.
  • Regeneron Pharmaceuticals, Inc, Tarrytown, New York.

Förderung

  • Regeneron Pharmaceuticals Inc
  • Bayer

Zitieren

APA

Javaheri, M., Vakharia, P. S., Kaden, T. R., Adrean, S., Ferrone, P. J., Niu, X., Maa, J., Rastogi, S., Patel, D., Moini, H., Reed, K., Berliner, A. J., & Do, D. V. (2026). Impact of Baseline Best-Corrected Visual Acuity on Outcomes with Aflibercept 8 mg in Patients with Diabetic Macular Edema. Ophthalmology Retina, 10(8), 887-890. https://doi.org/10.1016/j.oret.2026.03.018

Vancouver

Javaheri M, Vakharia PS, Kaden TR, Adrean S, Ferrone PJ, Niu X, et al. Impact of Baseline Best-Corrected Visual Acuity on Outcomes with Aflibercept 8 mg in Patients with Diabetic Macular Edema. Ophthalmology Retina. 2026;10(8):887-890. doi:10.1016/j.oret.2026.03.018

BibTeX
@article{Javaheri2026,
  author = {Javaheri, Michael and Vakharia, Priya S and Kaden, Talia R and Adrean, Sean and Ferrone, Philip J and Niu, Xiaomeng and Maa, Jenfue and Rastogi, Sharad and Patel, Disha and Moini, Hadi and Reed, Kimberly and Berliner, Alyson J and Do, Diana V},
  title = {Impact of Baseline Best-Corrected Visual Acuity on Outcomes with Aflibercept 8 mg in Patients with Diabetic Macular Edema},
  journal = {Ophthalmology Retina},
  year = {2026},
  volume = {10},
  number = {8},
  pages = {887--890},
  doi = {10.1016/j.oret.2026.03.018}
}
Kostenlos starten →